Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLSM

BlossomHill Therapeutics Inc

16.00

Aug 07 • 3:59 PM ET 0.00 (0.00%)

17.00

Aftermarket • 7:34 PM ET +1.00 (6.25%)

Healthcare Biotechnology USA Small NASD

Scroll to Statements

Index	-
Market Cap	465.28M
Enterprise Value	629.13M
Income	-
Sales	-
Book/sh	-5.23
Cash/sh	3.99
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	63
IPO	Aug 07, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	4.01
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	7.37
Current Ratio	7.37
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / No

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.00%
SMA50	0.00%
SMA200	0.00%
Trades

Shs Outstand	29.08M
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	- -
52W Low	- -
Volatility	- -
ATR (14)	0.80
RSI (14)	-
Beta	-
Rel Volume	-
Avg Volume	-
Volume	1,757,634

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	-
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	16.00
Price	16.00
Change %	0.00%

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.

PhDJing Rong Jean Cui

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BLSM

BlossomHill Therapeutics Inc

Upgrade your Finviz experience